Mark Levstik

2.2k total citations · 1 hit paper
37 papers, 1.6k citations indexed

About

Mark Levstik is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Mark Levstik has authored 37 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hepatology, 16 papers in Surgery and 13 papers in Epidemiology. Recurrent topics in Mark Levstik's work include Liver Disease and Transplantation (14 papers), Organ Transplantation Techniques and Outcomes (12 papers) and Liver Disease Diagnosis and Treatment (11 papers). Mark Levstik is often cited by papers focused on Liver Disease and Transplantation (14 papers), Organ Transplantation Techniques and Outcomes (12 papers) and Liver Disease Diagnosis and Treatment (11 papers). Mark Levstik collaborates with scholars based in Canada, United States and Saudi Arabia. Mark Levstik's co-authors include Magdy Elkashab, Gilles Pomier–Layrargues, Andrés Duarte‐Rojo, Robert P. Myers, Richard Kirsch, Melanie Beaton, Aaron Pollett, Pam Crotty, David Wong and Paul Marotta and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Mark Levstik

36 papers receiving 1.6k citations

Hit Papers

Feasibility and Diagnostic Performance of the Fibroscan X... 2011 2026 2016 2021 2011 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Feasibility and Diagnostic Performance of the Fibroscan XL Probe for Liver Stiffness Measurement in Overweight and Obese Patients
    2011 389 citations Robert P. Myers, Gilles Pomier–Layrargues et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Levstik Canada 18 1.1k 1.1k 482 170 160 37 1.6k
Virginia Clark United States 20 742 0.7× 643 0.6× 349 0.7× 38 0.2× 191 1.2× 57 1.4k
Eduardo Barroso Portugal 27 297 0.3× 1.1k 1.0× 1.2k 2.4× 52 0.3× 45 0.3× 92 2.3k
Ayse Aytaman United States 14 694 0.6× 732 0.7× 139 0.3× 19 0.1× 51 0.3× 33 1.0k
Zhi Ven Fong United States 28 303 0.3× 184 0.2× 1.2k 2.5× 151 0.9× 42 0.3× 122 2.3k
Lilian Schwarz France 23 257 0.2× 564 0.5× 979 2.0× 76 0.4× 9 0.1× 89 1.8k
Sheetal Kircher United States 22 222 0.2× 159 0.1× 199 0.4× 251 1.5× 24 0.1× 108 1.8k
Ramya Ramaswami United States 22 502 0.5× 373 0.3× 156 0.3× 111 0.7× 41 0.3× 75 1.6k
Roberta Angelico Italy 17 219 0.2× 438 0.4× 602 1.2× 142 0.8× 17 0.1× 81 1.1k
Yizhou Jiang United States 22 128 0.1× 233 0.2× 262 0.5× 59 0.3× 49 0.3× 93 1.9k
Lewis E. Foxhall United States 15 415 0.4× 117 0.1× 165 0.3× 176 1.0× 29 0.2× 29 1.5k

Countries citing papers authored by Mark Levstik

Since Specialization
Citations

This map shows the geographic impact of Mark Levstik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Levstik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Levstik more than expected).

Fields of papers citing papers by Mark Levstik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Levstik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Levstik. The network helps show where Mark Levstik may publish in the future.

Co-authorship network of co-authors of Mark Levstik

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Levstik. A scholar is included among the top collaborators of Mark Levstik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Levstik. Mark Levstik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Bell, Phoenix, Swan N. Thung, Mark Levstik, et al.. (2019). Hepatocellular adenoma(s) arising in nodular regenerative hyperplasia in a patient with systemic lupus erythematosus. Pathology - Research and Practice. 216(2). 152770–152770. 1 indexed citations
4.
Wanis, Kerollos Nashat, Arin L. Madenci, Mark S. Orloff, et al.. (2019). The meaning of confounding adjustment in the presence of multiple versions of treatment: an application to organ transplantation. European Journal of Epidemiology. 34(3). 225–233. 7 indexed citations
5.
Tun‐Abraham, Mauro Enrique, Kerollos Nashat Wanis, Hemant Sharma, et al.. (2019). Can we reduce ischemic cholangiopathy rates in donation after cardiac death liver transplantation after 10 years of practice? Canadian single-centre experience. PubMed. 62(1). 44–51. 6 indexed citations
6.
Goldberg, David S., Seth J. Karp, Maureen McCauley, et al.. (2017). Interpreting Outcomes in DCDD Liver Transplantation. Transplantation. 101(5). 1067–1073. 30 indexed citations
7.
McIntosh, Scott, Bandar Al‐Judaibi, Koji Tomiyama, et al.. (2017). Tobacco Use is a Modifiable Risk Factor for Post-Transplant Biliary Complications. Journal of Gastrointestinal Surgery. 21(10). 1643–1649. 7 indexed citations
8.
Beaton, M, Subrata Chakrabarti, Mark Levstik, et al.. (2013). Phase II clinical trial of phlebotomy for non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics. 37(7). 720–729. 62 indexed citations
9.
10.
Chande, Nilesh, Paul C. Adams, M Beaton, et al.. (2012). Meta‐analysis: vasoactive medications for the management of acute variceal bleeds. Alimentary Pharmacology & Therapeutics. 35(11). 1267–1278. 140 indexed citations
11.
Lingard, Lorelei, Allan McDougall, Mark Levstik, et al.. (2012). Representing complexity well: a story about teamwork, with implications for how we teach collaboration. Medical Education. 46(9). 869–877. 94 indexed citations
12.
Myers, Robert P., Gilles Pomier–Layrargues, Richard Kirsch, et al.. (2011). Feasibility and Diagnostic Performance of the Fibroscan XL Probe for Liver Stiffness Measurement in Overweight and Obese Patients. Hepatology. 55(1). 199–208. 389 indexed citations breakdown →
13.
Hernandez‐Alejandro, Roberto, Kris P Croome, Douglas Quan, et al.. (2011). Increased Risk of Severe Recurrence of Hepatitis C Virus in Liver Transplant Recipients of Donation After Cardiac Death Allografts. Transplantation. 92(6). 686–689. 28 indexed citations
14.
Myers, Robert P., Gilles Pomier–Layrargues, Richard Kirsch, et al.. (2011). Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe. Journal of Hepatology. 56(3). 564–570. 108 indexed citations
15.
Myers, Robert P., Gilles Pomier–Layrargues, Andrés Duarte‐Rojo, et al.. (2011). 341 PERFORMANCE OF THE FIBROSCAN XL PROBE FOR LIVER STIFFNESS MEASUREMENT IN OBESE PATIENTS: A MULTICENTER VALIDATION STUDY. Journal of Hepatology. 54. S136–S137. 3 indexed citations
16.
Katada, Kazuhiro, Mark Levstik, Douglas Quan, et al.. (2011). The clinical consequences of utilizing donation after cardiac death liver grafts into hepatitis C recipients. Hepatology International. 5(3). 830–833. 6 indexed citations
17.
Chan, Gabriel, Paul Marotta, Mark Levstik, et al.. (2009). Long-Term Outcomes of Emergency Liver Transplantation for Acute Liver Failure. Liver Transplantation. 15(12). 1696–1702. 40 indexed citations
18.
Parfitt, Jeremy, Paul Marotta, William Wall, et al.. (2007). Recurrent Hepatocellular Carcinoma After Transplantation. Liver Transplantation. 13(4). 543–551. 127 indexed citations
19.
Strickland, Donald K., et al.. (2002). Hepatitis C infection during treatment for childhood cancer: Pitfalls in diagnosis and management. Medical and Pediatric Oncology. 39(1). 58–59. 4 indexed citations
20.
Levstik, Mark, et al.. (1998). Eligibility and Exclusion of Hemochromatosis Patients as Voluntary Blood Donors. SHILAP Revista de lepidopterología. 12(1). 61–63. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Virginia Clark Breakdown of academic impact, for papers by Eduardo Barroso Breakdown of academic impact, for papers by Ayse Aytaman Breakdown of academic impact, for papers by Zhi Ven Fong Breakdown of academic impact, for papers by Lilian Schwarz Breakdown of academic impact, for papers by Sheetal Kircher Breakdown of academic impact, for papers by Ramya Ramaswami Breakdown of academic impact, for papers by Roberta Angelico Breakdown of academic impact, for papers by Yizhou Jiang Breakdown of academic impact, for papers by Lewis E. Foxhall
Rankless by CCL
2026